Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

OCEANIC-STROKE

Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
May 23, 2026, 08:15 | Voices
Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
Alexander Krupp, Executive Clinical Product Excellence Lead, VP at Bayer, shared on LinkedIn: ''Exciting news:…
Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health - Europe
May 21, 2026, 20:07 | Voices
Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health - Europe
Stephanie Becker, Senior Editor at The Lancet Regional Health - Europe, shared on LinkedIn: ''Exciting…
Ashkan Shoamanesh: FDA Grants Asundexian A Priority Review for Secondary Stroke Prevention
May 21, 2026, 06:54 | Science
Ashkan Shoamanesh: FDA Grants Asundexian A Priority Review for Secondary Stroke Prevention
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research…
Ashkan Shoamanesh: Factor XI Inhibition and the Future of Antithrombotic Therapy
Apr 21, 2026, 15:32 | Science
Ashkan Shoamanesh: Factor XI Inhibition and the Future of Antithrombotic Therapy
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research…
Abdulla A. Damluji: OCEANIC-STROKE Trial Analysis and Its Clinical and Market Implications
Apr 18, 2026, 18:54 | Science
Abdulla A. Damluji: OCEANIC-STROKE Trial Analysis and Its Clinical and Market Implications
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, shared on…
Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
Apr 12, 2026, 15:54 | Science
Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
Ralf Illing, Program and Solution Manager, Data and Systems Integration, STO at GE Healthcare, shared…
Catch the Brand-New Recap of the Phase III OCEANIC-STROKE Trial - ISTH
Apr 9, 2026, 15:06 | Voices
Catch the Brand-New Recap of the Phase III OCEANIC-STROKE Trial - ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn: ''Big trial. Big…
Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
Mar 16, 2026, 18:42 | Science
Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a…
Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
Feb 23, 2026, 12:02 | Insight
Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
Marios Georgakis, Research Group Leader and Physician at LMU Munich, Visiting Scientist at Broad Institute…
Ashkan Shoamanesh: OCEANIC-STROKE Focus on Stroke Subtypes and Response to Asundexian at ISC26
Feb 22, 2026, 07:08 | Voices
Ashkan Shoamanesh: OCEANIC-STROKE Focus on Stroke Subtypes and Response to Asundexian at ISC26
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research…
Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Feb 20, 2026, 09:35 | Science
Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Gregory Makris, Senior Director in Global Medical Affairs, Cardiovascular and Thrombosis at Bayer, shared on…
Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
Feb 7, 2026, 14:57 | Voices
Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn: ''A new…
Shekher Bose: Asundexian’s Targeted Factor XIa Inhibition May Transform Secondary Stroke Prevention Strategies
Feb 6, 2026, 15:20 | Voices
Shekher Bose: Asundexian’s Targeted Factor XIa Inhibition May Transform Secondary Stroke Prevention Strategies
Shekher Bose, Client Partner at Beyondsight Intelligence, reposted Beyondsight Intelligence's post on LinkedIn, adding: ''Asundexian’s targeted…
C Michael Gibson Discussing The Results of The Phase III OCEANIC-STROKE Trial with Mike Sharma
Feb 5, 2026, 13:04 | Insight
C Michael Gibson Discussing The Results of The Phase III OCEANIC-STROKE Trial with Mike Sharma
C Michael Gibson, President and CEO at Baim Institute for Clinical Research, shared on LinkedIn:…
Joanna Sadowska: Bayer’s Asundexian Reduces Ischemic Stroke Risk in Phase 3 Trial
Dec 2, 2025, 09:50 | Drugs
Joanna Sadowska: Bayer’s Asundexian Reduces Ischemic Stroke Risk in Phase 3 Trial
Joanna Sadowska, Biopharma Account Specialist, shared on LinkedIn: ”Big News - Bayer’s asundexian reduces ischaemic…
Jack Shuang Hou Shares Major Neurology Updates This Week
Nov 29, 2025, 17:23 | Insight
Jack Shuang Hou Shares Major Neurology Updates This Week
Jack Shuang Hou, Scientific Director at Jtests, shared on LinkedIn: ''FDA Approves Intrathecal Zolgensma, Ozempic…
Thomas M Zollner on OCEANIC-STROKE Study: Amazingly Good News for Patients With Stroke
Nov 24, 2025, 15:04 | Drugs
Thomas M Zollner on OCEANIC-STROKE Study: Amazingly Good News for Patients With Stroke
Thomas M Zollner, Reproductive Health Cluster Lead at Bayer, reposted from Alexander Krupp on LinkedIn:…
OCEANIC-STROKE Revives Optimism for Factor XI Inhibitors
Nov 24, 2025, 11:56 | Innovation
OCEANIC-STROKE Revives Optimism for Factor XI Inhibitors
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, shared on X:…
Ashkan Shoamanesh Shares OCEANIC-STROKE Trial’s Successful Endpoints
Nov 24, 2025, 01:39 | Drugs
Ashkan Shoamanesh Shares OCEANIC-STROKE Trial’s Successful Endpoints
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research…
Dirk Sibbing on OCEANIC-STROKE Demonstrationg Superiority of Asundexian vs. Placebo
Nov 23, 2025, 15:15 | Insight
Dirk Sibbing on OCEANIC-STROKE Demonstrationg Superiority of Asundexian vs. Placebo
Dirk Sibbing, Professor, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, shared…
All: 20 Posts: 1 - 100
NewsFeed